Yousefi H, Khosla M, Lauterboeck L, Okpechi SC, et al. A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming. Oncogene 2022 Oct 15. pii: 10.1038/s41388-022-02497.
PMID: 36243802